# Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemotherapy

> **NCT01934179** · — · TERMINATED · sponsor: **Fox Chase Cancer Center** · enrollment: 6 (actual)

## Conditions studied

- Mucinous Adenocarcinoma of the Colon
- Mucinous Adenocarcinoma of the Rectum
- Signet Ring Adenocarcinoma of the Colon
- Signet Ring Adenocarcinoma of the Rectum
- Stage IIIA Colon Cancer
- Stage IIIA Rectal Cancer
- Stage IIIB Colon Cancer
- Stage IIIB Rectal Cancer
- Stage IIIC Colon Cancer
- Stage IIIC Rectal Cancer
- Stage IV Colon Cancer
- Stage IV Rectal Cancer

## Interventions

- **OTHER:** cytology specimen collection procedure
- **OTHER:** laboratory biomarker analysis
- **OTHER:** questionnaire administration

## Key facts

- **NCT ID:** NCT01934179
- **Lead sponsor:** Fox Chase Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2013-10
- **Primary completion:** 2015-09-11
- **Final completion:** 2015-09-11
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Low Accrual Rate
- **Last updated:** 2018-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01934179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01934179, "Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemotherapy". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01934179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*